Siemens Healthineers Launches Brain Health Research Portfolio with First Biomarker Assays Now Available
SIEMENS AG SPONS ADR (SIEGY)
NASDAQ:AMEX Investor Relations:
siemens.com/investor
Company Research
Source: GlobeNewswire
Tarrytown, New York, USA, March 18, 2026 (GLOBE NEWSWIRE) -- Research assays help generate evidence about whether biomarkers can advance disease managementNovel RUO tests can help scientists understand neurological function and disease progressionCollaborative research is underway to translate scientific discovery into actionable evidence Siemens Healthineers announced today its offerings for brain health research are expanding, with the brain-derived, fully automated Atellica IM Phosphorylated tau 217 (pTau217) and Atellica IM Brain Derived Tau (BDTau) assays now available for research use1. Every year, there are nearly 10 million new cases of dementia diagnosed worldwide2. Alzheimer’s disease is the most common, contributing to 60–70% of cases, though it affects many more people over time as these individuals become adversely impacted and increasingly dependent on others for their care2. The blood tests from Siemens Healthineers offer researchers chemiluminescent immunoas
Show less
Read more
Impact Snapshot
Event Time:
SIEGY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SIEGY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SIEGY alerts
High impacting SIEMENS AG SPONS ADR news events
Weekly update
A roundup of the hottest topics
SIEGY
News
- Varian TrueBeam Receives FDA Clearance for Low-Dose Radiotherapy for Adults with Medically Refractory Osteoarthritis [Yahoo! Finance]Yahoo! Finance
- Siemens Healthineers Launches Brain Health Research Portfolio with First Biomarker Assays Now Available [Yahoo! Finance]Yahoo! Finance
- Siemens launches Fuse EDA AI Agent for automation across semiconductor, 3D IC and PCB system workflowsPR Newswire
- Siemens to Help Build AI-Ready Scientific Infrastructure as Part of U.S. Department of Energy's Genesis Mission [Yahoo! Finance]Yahoo! Finance
- Siemens to Help Build AI-Ready Scientific Infrastructure as Part of U.S. Department of Energy’s Genesis MissionBusiness Wire